• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病患儿的过敏性接触性皮炎:一个新出现的问题。

Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue.

机构信息

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy.

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Allergy Unit, University of Messina, Messina, Italy.

出版信息

Diabetes Res Clin Pract. 2020 Apr;162:108089. doi: 10.1016/j.diabres.2020.108089. Epub 2020 Feb 19.

DOI:10.1016/j.diabres.2020.108089
PMID:32087268
Abstract

AIMS

Aim of our observational study was to assess the prevalence of allergic contact dermatitis among children and adolescents with type 1 diabetes who use technological devices for diabetes treatment and its management. Secondary outcome was to identify possible clinical and/or demographic variables that could be associated to contact dermatitis.

METHODS

Among a total of 215 patients using insulin pumps and/or glucose sensors followed-up at our Pediatric Diabetes Centre between January and September 2018, 64 patients were enrolled and 42 (19 male and 23 female) completed the study. Demographic and clinical features of the study population were statistically analysed. All the patients underwent patch testing with specific allergens belonged to resin and acrylate classes.

RESULTS

Eighteen patients experienced skin reactions suggestive of allergic contact dermatitis, demonstrating a prevalence of 8.4%. None of the demographic or clinical variables were associated to skin reactions. Colophonium was the most identified sensitizing allergen (87.5% of the cases).

CONCLUSIONS

The rate of sensitization to allergens included into diabetes devices among pediatric patients is higher than commonly assumed. Well-designed studies are needed to better investigate the association between type 1 diabetes and allergic contact dermatitis. Moreover, we suggest that manufactures should supply detailed information about adhesives in order to avoid dermatological complications and consequently a worsening of disease management and patients' quality of life.

摘要

目的

本观察性研究旨在评估使用糖尿病治疗和管理技术设备的 1 型糖尿病儿童和青少年中过敏性接触性皮炎的患病率。次要结局是确定可能与接触性皮炎相关的临床和/或人口统计学变量。

方法

在 2018 年 1 月至 9 月期间在我们的儿科糖尿病中心接受胰岛素泵和/或葡萄糖传感器治疗的 215 名患者中,共有 64 名患者入组,其中 42 名(19 名男性和 23 名女性)完成了研究。对研究人群的人口统计学和临床特征进行了统计学分析。所有患者均接受了特定过敏原的斑贴试验,这些过敏原属于树脂和丙烯酸盐类。

结果

18 名患者出现了疑似过敏性接触性皮炎的皮肤反应,患病率为 8.4%。没有任何人口统计学或临床变量与皮肤反应相关。松香是最常见的致敏过敏原(占病例的 87.5%)。

结论

在儿科患者中,对糖尿病设备中包含的过敏原的致敏率高于通常认为的水平。需要进行精心设计的研究,以更好地调查 1 型糖尿病与过敏性接触性皮炎之间的关系。此外,我们建议制造商应提供有关粘合剂的详细信息,以避免皮肤并发症,从而改善疾病管理和患者的生活质量。

相似文献

1
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue.1 型糖尿病患儿的过敏性接触性皮炎:一个新出现的问题。
Diabetes Res Clin Pract. 2020 Apr;162:108089. doi: 10.1016/j.diabres.2020.108089. Epub 2020 Feb 19.
2
Contact dermatitis caused by glucose sensors, insulin pumps, and tapes: Results from a 5-year period.由葡萄糖传感器、胰岛素泵和胶带引起的接触性皮炎:5 年期间的结果。
Contact Dermatitis. 2021 Feb;84(2):75-81. doi: 10.1111/cod.13664. Epub 2020 Sep 7.
3
[Contact allergy due to insulin pumps and glucose sensor systems].胰岛素泵和葡萄糖传感器系统引起的接触性过敏
Hautarzt. 2020 Mar;71(3):205-210. doi: 10.1007/s00105-019-04533-x.
4
Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: Irritant contact dermatitis or allergic contact dermatitis?糖尿病葡萄糖传感器和胰岛素泵的皮肤不良反应:刺激性接触性皮炎还是过敏性接触性皮炎?
Contact Dermatitis. 2020 Jul;83(1):25-30. doi: 10.1111/cod.13529. Epub 2020 May 4.
5
Allergic Contact Dermatitis to Components of Wearable Adhesive Health Devices.对可穿戴粘性健康设备组件的过敏性接触性皮炎。
Dermatitis. 2020 Sep/Oct;31(5):283-286. doi: 10.1097/DER.0000000000000575.
6
Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients.1 型糖尿病患者中由葡萄糖传感器引起的过敏接触性皮炎。
Contact Dermatitis. 2019 Sep;81(3):161-166. doi: 10.1111/cod.13337. Epub 2019 Jul 10.
7
Contact dermatitis from glucose sensors in Spain: A multicentric approach.西班牙葡萄糖传感器所致接触性皮炎:一种多中心研究方法。
Contact Dermatitis. 2021 Nov;85(5):554-562. doi: 10.1111/cod.13924. Epub 2021 Aug 25.
8
Contact Dermatitis to Diabetes Medical Devices.接触性皮炎与糖尿病医疗器械。
Int J Mol Sci. 2023 Jun 27;24(13):10697. doi: 10.3390/ijms241310697.
9
High Prevalence of Skin Reactions Among Pediatric Patients with Type 1 Diabetes Using New Technologies: The Alarming Role of Colophonium.新技术在 1 型糖尿病患儿中的应用导致皮肤反应高发:松香的惊人作用。
Diabetes Technol Ther. 2020 Jan;22(1):53-56. doi: 10.1089/dia.2019.0236.
10
Role of acrylates in the development of contact dermatitis in diabetic patients-A Polish dermatology tertiary centre experience.丙烯酸酯类在糖尿病患者接触性皮炎发展中的作用——波兰皮肤科三级中心的经验。
Contact Dermatitis. 2024 Feb;90(2):126-133. doi: 10.1111/cod.14436. Epub 2023 Oct 15.

引用本文的文献

1
7. Diabetes Technology: Standards of Care in Diabetes-2025.7. 糖尿病技术:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S146-S166. doi: 10.2337/dc25-S007.
2
Allergic contact dermatitis caused by glucose sensors and insulin pumps: A full review: Part 2. Case reports and case series, clinical features, patch test procedures, differentiation from irritant dermatitis, management of allergic patients and (proposed) legislation.由葡萄糖传感器和胰岛素泵引起的过敏性接触性皮炎:全面综述:第2部分。病例报告和病例系列、临床特征、斑贴试验程序、与刺激性皮炎的鉴别、过敏患者的管理及(拟议的)立法
Contact Dermatitis. 2025 Mar;92(3):164-175. doi: 10.1111/cod.14697. Epub 2024 Nov 26.
3
Insulin Pump Therapy and Adverse Skin Reactions With Focus on Allergic Contact Dermatitis in Individuals Living With Diabetes Mellitus: A Systematic Review and Clinical-Based Update.
胰岛素泵治疗与不良皮肤反应,重点关注糖尿病患者的过敏性接触性皮炎:一项系统评价及基于临床的更新
J Diabetes Sci Technol. 2024 Nov;18(6):1300-1312. doi: 10.1177/19322968241252613. Epub 2024 Jun 10.
4
7. Diabetes Technology: Standards of Care in Diabetes-2024.7. 糖尿病技术:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.
5
First International Survey on Diabetes Providers' Assessment of Skin Reactions in Youth With Type 1 Diabetes Using Technological Devices.关于糖尿病医护人员对1型糖尿病青少年使用技术设备时皮肤反应评估的首次国际调查。
J Diabetes Sci Technol. 2025 May;19(3):666-672. doi: 10.1177/19322968231206155. Epub 2023 Oct 17.
6
Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes.1型糖尿病患者使用糖尿病设备的负担体验,这些负担会影响设备的采用率和最佳使用情况。
Endocr Connect. 2023 Sep 8;12(10). doi: 10.1530/EC-23-0193. Print 2023 Oct 1.
7
7. Diabetes Technology: Standards of Care in Diabetes-2023.7. 糖尿病技术:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007.
8
The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes.胰岛素诱导性脂肪营养不良对1型糖尿病患儿血糖变异性的影响。
Children (Basel). 2022 Jul 20;9(7):1087. doi: 10.3390/children9071087.
9
Technologies for Type 1 Diabetes and Contact Dermatitis: Therapeutic Tools and Clinical Outcomes in a Cohort of Pediatric Patients.1 型糖尿病和接触性皮炎的技术:儿科患者队列中的治疗工具和临床结果。
Front Endocrinol (Lausanne). 2022 Mar 15;13:846137. doi: 10.3389/fendo.2022.846137. eCollection 2022.
10
What We Have Learned-Milestones in Pediatric Contact Dermatitis.我们所学到的——儿童接触性皮炎的里程碑
Curr Dermatol Rep. 2022;11(1):1-12. doi: 10.1007/s13671-022-00353-w. Epub 2022 Mar 26.